AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS
· Delayed Price · Currency is USD
0.0126
+0.0016 (14.55%)
Mar 6, 2026, 2:50 PM EST
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $4.58 million as of March 6, 2026. Its market cap has increased by 391.06% in one year.
Market Cap
4.58M
Enterprise Value
n/a
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has increased from 1.98M to 4.58M, an increase of 131.08%. That is a compound annual growth rate of 6.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GPL Holdings | 4.17M |
| Mosaic ImmunoEngineering | 3.77M |
| Enzon Pharmaceuticals | 4.50M |
| Burzynski Research Institute | 3.29M |
| Clearside Biomedical | 3.25M |
| Galera Therapeutics | 3.24M |
| Bioxytran | 4.98M |
| Nymox Pharmaceutical | 5.42M |